We only have this paper's title and publication details.
Read it at the sourceObjective: To evaluate the clinical outcome of omalizumab in various diseases.
No takes yet. Share an insight, caveat, or question.
Öztop et al. (2022) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: